Satu Mare

Romania

35 total trials 19 recruiting

Filter these 35 trials by phase, condition, sponsor and more.

Open in Search →

A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended recruitment

2023-509190-23-00 5 2024-09-03 Atherosclerotic Cardiovascular Disease Elevated lp(a)
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-OUTCOMES) Ended recruitment

2023-508630-34-00 5 2024-05-28 Overweight
A Study of Tirzepatide (LY3298176) on the Reduction of Morbidity and Mortality in Adults With Obesity (SURMOUNT- MMO) Ended recruitment

2022-501744-15-00 5 2023-01-23 Obesity, Overweight
Research study on whether semaglutide works in people with non-alcoholic steatohepatitis (NASH) Ended recruitment

2023-506962-30-00 5 2021-03-29 Non-alcoholic steatohepatitis (NASH)
A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered i … Ended

2023-506696-10-00 5 2024-06-18 Non-Small Cell Lung Cancer
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or With … Ended

2023-507280-18-00 5 2024-02-23 Type 2 Diabetes
A Study of LY3437943 in Participants Who Have Obesity or Overweight (TRIUMPH-1) Ended

2023-503657-35-00 5 2023-10-10 Obesity
A Study of Daily Oral Orforglipron Compared with Insulin Glargine in Participants with Type 2 Diabetes and Obesity or Overweight at Increase … Ended

2022-502833-25-00 5 2023-08-02 Obesity
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) Ended

2022-500101-41-00 6 2023-06-07 Type 2 Diabetes
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis … Ended

2023-503794-38-00 5 2022-11-24 Prevention of stroke or systemic embolism in atrial fibrillation
A research study to look into how semaglutide, together with a lower dose of insulin glargine, compares to a higher dose of insulin glargine … Ended

2024-510612-75-00 5 2022-08-31 Participants with T2D and overweight

Showing 25–35 of 35 trials